Abstract
Investors are turning their attention to antiviral drug discovery because
there is a renewed recognition of the promising opportunities in this $20bn
market. Twenty years from the inception of focused antiviral drug research,
there are 8 blockbuster drugs currently on the market. Its double-digit
growth makes it a standout segment within the general anti-infective
therapeutic class. You should be maximizing your opportunities in this market.
The opportunities for success are there now, you should capitalize on them
immediately.
The key driver of the market is the rapid development of resistance to
existing therapies by the evolving viruses. The constant need to update the
pipeline fuels your investigative and commercial interest in this market - so
you must act on this today. This report - Global Antivirals Market, 2008-2023
- analyses the global antiviral market comprehensively, outlining where you
should aim your future developments to guarantee success. The analyses tackle
different aspects of the market, including the leading therapeutic classes,
leading antiviral products, key industrial players as partners and financial
prospects and opportunities. The report also delivers in-depth predictions
concerning how the market will develop from present until 2023.
Global Antivirals Market, 2008-2023 examines the market for antivirals
critically, through comprehensive primary and secondary research. In addition
to consultation with experts in the industry, this research involved a
detailed study of policy documents, industrial reports and relevant news.
Essentially, visiongain also applied unique in-house techniques such as our
developed financial forecasting, SWOT analyses and qualitative projections
which are unavailable elsewhere. The result is a comprehensive market-focused
study with detailed financial analyses and uniquely informed opinion on the
future of the antivirals market.
In particular, our new Global Antivirals Market 2008-2023 report concentrates on the following essential aspects of that market:
- Antiviral drugs assessment and opportunities
- Key industrial players in the global antivirals market
- Forecasts of global antivirals market from 2008-2023, including in-house
developed forecasts of the leading therapeutic agents
- Forecasts for the antiviral therapies in the seven leading developed
pharmaceutical country markets and two leading developing markets
- Drivers and opportunities in the global antivirals market
- Restraints and threats in the global antivirals market
- Key opinion from relevant experts - full interview transcripts are
included with the report (unavailable anywhere else)
- Coverage of pipeline developments in the antivirals market, with
discussion of trends from the present onwards
Why you should buy this report:
- To receive a comprehensive analysis of the prospects for the antivirals
industry from 2008-2023, including sales forecasts, major growth areas and
most exciting pipeline developments
- To discover predicted revenues, growth rates and other key metrics in the
global antivirals market from 2008-2023, with leading brands and principal
market segments covered
- To determine the forces that influence the global antivirals market:
- Drivers and restraints on that market
- Competition
- Strengths, weaknesses, opportunities and threats.
- To find out where the global antivirals market is heading from 2008
onwards - both technologically and commercially
The information contained in this report is not available in any other source
and is essential reading for you and your colleagues. By ordering and reading
this report you can gain market advantage on your competitors today. When
aligned with your in-house findings we are confident you will continue to
succeed over the next 15 years.
| 
View Cart
